Answers are grounded in this paper and cite their sources.
Systematic review reveals vitamin D deficiency prevalence of 56.72% in knee osteoarthritis patients, highlighting regional variations.
Background: Low serum 25-hydroxyvitamin D (25[OH]D) levels affect bone remodeling, contributing to the development and progression of knee osteoarthritis (OA). Aim: This meta-analysis aimed to estimate the prevalence of vitamin D deficiency in patients with knee OA. Methods: A systematic search was conducted in Europe PMC, Google Scholar, Scopus, Scilit, and Web of Science for studies published until 8 August 2024 that reported the prevalence and contributing factors of hypovitaminosis D in knee OA patients. Study quality was assessed using the Newcastle–Ottawa Scale. A random-effect meta-analysis with Freeman–Tukey double arcsine transformation estimated the pooled prevalence of vitamin D deficiency. Results: Out of 1695 records identified, 26 studies ( n = 4248 patients) met the inclusion criteria. The pooled prevalence of vitamin D deficiency was 56.72% (95% CI: 46.93–66.25). No significant difference was observed across publication periods of 2015–2019 ( p = 0.465) and 2020–2024 ( p = 0.407). Patients with an average body mass index (BMI) ≥28 kg/m² had a higher prevalence (65.62%, 95% CI: 49.23–80.32) compared to those with BMI <28 kg/m² (37.63%, 95% CI: 24.72–51.48). The prevalence was significantly higher in European countries (65.92%, 95% CI: 47.17–82.43) than in the USA ( p = 0.046). In Asia, the Middle East, and North Africa, prevalences were 60.96% (95% CI: 42.32–78.08) and 63.11% (95% CI: 43.8–80.47), respectively. Conclusion: Over half of knee OA patients had vitamin D deficiency, with higher prevalence in Europe and among individuals with obesity. Targeted screening for 25(OH)D levels in knee OA patients is recommended.
No takes yet. Share an insight, caveat, or question.
Iqhrammullah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: